🔗 Share this article

An underground market for unlicensed slimming drugs is being driven by TikTok fitness influencers and vendors on communication apps, based on new investigations.

Investigational Treatment Acquiring Traction Online

Retatrutide, which is still in research studies, is being promoted by social media influencers for its alleged fat-burning properties. Viewers are urged to contact these profiles directly for supplier links, while also receiving discount codes.

Active Commerce on Social Networks

Separately, a robust trade exists on Telegram, where communities with numerous of participants share comparison photos, injection guides and claims of next-day British shipping. Vendors market the substance there before redirecting buyers to other platforms for purchases.

Understanding Retatrutide

Retatrutide is an experimental injection developed by American pharmaceutical company Eli Lilly. The drug targets three intestinal hormones – glucagon-like peptide-1, glucose-dependent insulinotropic polypeptide and glucagon. Preliminary studies indicate it could assist individuals reduce up to 25% of their body weight. Referred to as the “triple G”, the drug is being hailed online as the successor to Ozempic.

Medical Professionals Voice Concerns

Nevertheless, doctors and chemists have warned that the distribution of what is still an unlicensed medication in the UK is worrisome and could result in users injecting products of unknown origin.

Several professionals stated the demand for the experimental drug could be connected to the rising price of licensed weight loss products such as Mounjaro.

Legal Status and Implementation

Marketing retatrutide on TikTok or messaging apps is illegal in the United Kingdom, as it is an unlicensed drug that cannot be promoted or distributed for human use under the Human Medicines Regulations 2012.

Some influencers try to sidestep the regulations by referring to the drug as a “research chemical” or describing it as “not for human consumption”. Retatrutide is not a controlled substance, but promotion and supply can still violate medicines, marketing, and customer laws, risking penalties, legal action or imprisonment.

Platform Response and Content Elimination

Based on TikTok, the platform has taken down problematic content and banned associated hashtags and query recommendations. The company said it was committed to maintaining the service secure and allocating resources in enhancing enforcement strategies.

Digital Marketplace Operations

Investigations also found groups with up to nine thousand participants selling retatrutide using the platform's integrated discovery tool, which operates like a online catalog. Entering “retatrutide” instantly displays channels with numerous of members, filled with photos of weight loss, glowing testimonials and step-by-step instructions for preparing or injecting at home.

Within moments of joining one group, a seller shared contact information, where most purchases take place. The vendor sent an instruction manual and guaranteed shipping within 48 hours. When asked whether the substance was genuine, one seller said: “You can’t be sure.” Another provided a image of a supposed laboratory certificate. None inquired about body mass, health issues or past usage.

Item Details and Costs

Inside these groups, messages display dark colored parcels with postal service labels, stating to include new batches. One message read: “It took eight of us to load them this morning.”

Customers can choose between powder vials, prepared at residence with sterile water, or ready-to-use pens typically priced at £160 for 20 milligrams. When asked how long a injector should be used, sellers give contradictory responses ranging from a few weeks to “depends on your body”.

Service Moderation and Safety Measures

A spokesperson for the messaging service said it actively moderated harmful material on its service including material that encouraged the “misuse of controlled medications”. The company noted that it eliminated “millions of pieces of harmful content each day”.

Healthcare Professional Cautions

“People are administering materials they can’t verify. Although the science behind this drug is valid, these digital versions may not include what they advertise,” said Jason Murphy, the director of pharmacy at Chemist4U.

Dr Crystal Wyllie of Asda Online Doctor connected the increase in demand to current price rises for authorized slimming drugs such as Mounjaro. “With costs increasing, patients are using online platforms. But counterfeit treatments are highly risky. You can’t be certain what’s contained or whether the conditions they were produced in was sterile,” she said.

Her team has previously encountered individuals injured by personal administration from unconfirmed sources. “We understand the disappointment, but buying from messaging apps or communication platforms is gambling with your well-being,” said Wyllie. “These materials could be contaminated or incorrectly dosed.”

Producer Position

A representative from Eli Lilly stated the substance was in phase 3 research studies and had not been evaluated or approved by any regulatory agency globally. “Therefore at this point no one can sell [it] for human use,” they explained, adding that any item “misleadingly claiming itself as a Lilly investigational substance not yet authorized … may expose patients to potentially significant health risks”.